Early Plasmacytoid Dendritic Cell Changes Predict Plasma HIV Load Rebound during Primary Infection
Author(s) -
Jérôme Pacanowski,
Leyla Develioglu,
Isabelle Kamga,
Martine Sinet,
Moı̈se Desvarieux,
PierreMarie Girard,
Anne Hosmalin
Publication year - 2004
Publication title -
the journal of infectious diseases
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/425020
Subject(s) - immunology , viral load , virus , human immunodeficiency virus (hiv) , flow cytometry , dendritic cell , immune system , plasmacytoid dendritic cell , medicine , antiretroviral therapy , virology , lentivirus , viral disease , biology
During human immunodeficiency virus (HIV) infection, interruption of highly active antiretroviral therapy (HAART) is usually followed by virus load rebound. Previous data have suggested a role for plasmacytoid dendritic cells (pDCs) in anti-HIV innate immunity. Here, the number of pDCs was measured by flow cytometry before, during, and after receipt of HAART in 7 patients with documented primary HIV-1 infection. A negative correlation was evidenced between pDC counts after 1 month of HAART and mean plasma virus load after interruption of HAART (r2=0.85; Spearman's partial rho =-0.92; P=.03). pDC counts during treatment might help predict immune replication control after interruption of HAART.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom